KIRSTEN VAN DEMARK: Open Payments
NPI 1508507161 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 35 payments from 13 companies in 2025. Trend: 2023 $799 · 2024 $342 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $196 |
| Amgen Inc. | 9 | $156 |
| Boston Scientific Corporation | 2 | $154 |
| Novartis Pharmaceuticals Corporation | 5 | $77 |
| Merck Sharp & Dohme LLC | 4 | $65 |
| PFIZER INC. | 3 | $62 |
| Novo Nordisk Inc | 2 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| CVRx, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: SAPIEN 3 Ultra RESILIA, Repatha, WATCHMAN FLX, LEQVIO, VERQUVO, Wegovy, VYNDAQEL, ONPATTRO.
Industry payments across SC — which companies pay providers there.
